合成生物学被誉为是继“DNA 双螺旋结构”和“基因组技术”之后的第三次生命科学革命，被认为是生命科学研究的一种新范式，更是生物制造与生物经济领域变革性发展的核心驱动力。作为一项关键的颠覆性技术，它正推动生物制造迈入4.0时代。这对于全球而言，具有重构物质生产逻辑以推动可持续性发展、突破传统定义边界以保障供应链安全、重塑全球产业版图以抢抓未来全新制高点的重要战略意义。发展合成生物学和生物制造产业高度契合我国可持续发展的重大战略需求，因此我国当前正加大力度从技术研发到产业布局实现全链条推进。全国多地相继出台相关政策，通过资金扶持、产业集聚和技术创新等举措，推动合成生物与生物制造产业从战略规划不断纵深向多领域发展。
Synthetic biology is hailed as the third revolution in life sciences following the "DNA double helix structure" and "genome technology". It is regarded not only as a new paradigm for life science research but also as the core driving force behind the transformative development of the biomanufacturing and bioeconomy sectors. As a key disruptive technology, it is propelling biomanufacturing into the 4.0 era. Globally, this holds significant strategic importance: it can restructure the logic of material production to advance sustainable development, break through traditional defined boundaries to ensure supply chain security, and reshape the global industrial landscape to seize new commanding heights in the future.
The development of the synthetic biology and biomanufacturing industries is highly aligned with China's major strategic needs for sustainable development. Therefore, China is currently intensifying efforts to promote the entire chain from technological research and development to industrial layout. Many regions across the country have successively introduced relevant policies, and through measures such as financial support, industrial agglomeration, and technological innovation, they are driving the synthetic biology and biomanufacturing industries to develop in depth from strategic planning to multiple fields.
如果您对中国合成生物与生物制造市场有进一步的研究需求，请联系我们：
沙利文 孙榕女士
E-mail: skyler.sun@frostchina.com
